One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Flashback Foreword: FACT Scale and Changes in Quality of Life.
Wheeler, Stephanie B. PhD, MPH 1,2,3,,
doi : 10.1200/JCO.23.01979
Volume 41(35) pgs. 5333-5477 December 10, 2023
The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure.
Cella, D F; Tulsky, D S; Gray, G; Sarafian, B; Linn, E; Bonomi, A; Silberman, M; Yellen, S B; Winicour, P; Brannon, J
doi : 10.1200/JCO.22.02775
Interpreting the Significance of Changes in Health-Related Quality-of-Life Scores.
Osoba, D; Rodrigues, G; Myles, J; Zee, B; Pater, J
doi : 10.1200/JCO.22.02776
Speeding up Antibody-Drug Conjugate Development in Pretreated EGFR-Mutant Non-Small-Cell Lung Cancer.
Hendriks, Lizza E.L. MD, PhD 1,,; Remon, Jordi MD, PhD 2,
doi : 10.1200/JCO.23.01830
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.
Goodwin, Pamela J. MD 1,,; Chen, Bingshu E. PhD 2; Gelmon, Karen A. MD 3,; Whelan, Timothy J. MD 4,; Ennis, Marguerite PhD 5; Lemieux, Julie MD 6,; Ligibel, Jennifer A. MD 7; Hershman, Dawn L. MD 8,; Mayer, Ingrid A. MD 9,; Hobday, Timothy J. MD 10,; Bliss, Judith M. MSc 11,; Rastogi, Priya MD 12,; Rabaglio-Poretti, Manuela MD 13; Thompson, Alastair M. MD 14,; Rea, Daniel W. PhD 15,; Stos, Paul M. BSc (Hon) 2; Shepherd, Lois E. MD 2; Stambolic, Vuk PhD 16,17; Parulekar, Wendy R. MD 2
doi : 10.1200/JCO.23.00296
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy.
Yu, Helena A. MD 1,,; Goto, Yasushi MD 2,; Hayashi, Hidetoshi MD, PhD 3,; Felip, Enriqueta MD, PhD 4,; Chih-Hsin Yang, James MD, PhD 5,; Reck, Martin MD, PhD 6,; Yoh, Kiyotaka MD 7,; Lee, Se-Hoon MD, PhD 8,; Paz-Ares, Luis MD, PhD 9,; Besse, Benjamin MD, PhD 10,; Bironzo, Paolo MD, PhD 11,; Kim, Dong-Wan MD, PhD 12,; Johnson, Melissa L. MD 13,; Wu, Yi-Long MD 14,; John, Thomas PhD, MBBS, FRACP 15,; Kao, Steven PhD, MBChB, BHB, FRACP 16,; Kozuki, Toshiyuki MD, PhD 17,; Massarelli, Erminia MD, PhD, MS 18,; Patel, Jyoti MD 19,; Smit, Egbert MD, PhD 20,; Reckamp, Karen L. MD 21,; Dong, Qian PhD 22,; Shrestha, Pomy MBBS 22,; Fan, Pang-Dian MD, PhD 22,; Patel, Parul MS 22,; Sporchia, Andrea MD 22,; Sternberg, David W. MD, PhD 22,; Sellami, Dalila MD 22,; Janne, Pasi A. MD, PhD 23,
doi : 10.1200/JCO.23.01476
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.
Lewis, Katharine L. BMedSci, MBBS (Hons) 1,2,3,; Jakobsen, Lasse H. PhD, MSc 4,; Villa, Diego MD, MPH 5,; Smedby, Karin E. MD 6,; Savage, Kerry J. MD, MSc 5,; Eyre, Toby A. MD, MBChB 7,; Cwynarski, Kate MD, PhD 8,; Bishton, Mark J. PhD, MBChB 9,10,; Fox, Christopher P. MD, PhD 9,10,; Hawkes, Eliza A. MBBS(Hons), DMedSci 11,12,; Maurer, Matthew J. MS, DMSc 13; El-Galaly, Tarec C. MD, DMSc 4; Cheah, Chan Y. MBBS, DMSc 1,2,3,14,,; on behalf of the International CNS Prophylaxis Study Group; the International CNS Prophylaxis Study Group; Bobillo, Sabela; Caporn, Paris L.; Van Zyl, Joan; Klanova, Magdalena; Trneny, Marek; Puckrin, Robert; Stewart, Douglas A.; Tun, Aung M.; Thanarajasingam, Gita; Nair, Ranjit; Nastoupil, Loretta; Djebbari, Faouzi; Joffe, Erel; Eloranta, Sandra; Harrysson, Sara; Sehn, Laurie H.; Maliske, Seth M.; Poonsombudlert, Kittika; Guo, Xiao Y.; Hapgood, Greg; Manos, Kate; Khwaja, Jahanzaib; Minson, Adrian; Dickinson, Michael; Ovlisen, Andreas K.; Gregory, Gareth P.; Gilbertson, Michael; Streit, Isaac T.; Scott, Hamish W.; Ku, Matthew; de Mel, Sanjay; Ying Yong, Kar; Xin, Liu; Mokoonlall, Mridula; Talaulikar, Dipti; Hamad, Nada; Srinivasan, Sathia S.; McVilly, Nicholas L.; Johnston, Anna M.; Brunner, Matthew J.; Pophali, Priyanka A.
doi : 10.1200/JCO.23.00365
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649.
Moehler, Markus MD 1,; Xiao, Hong PhD 2,,; Blum, Steven I. MBA 2,; Elimova, Elena MD 3,; Cella, David PhD 4,; Shitara, Kohei MD 5,; Ajani, Jaffer A. MD 6,; Janjigian, Yelena Y. MD 7,; Garrido, Marcelo MD 8,; Shen, Lin MD 9,; Yamaguchi, Kensei MD 10,; Liu, Tianshu MD 11; Schenker, Michael MD, PhD 12,; Kowalyszyn, Ruben MD 13,; Bragagnoli, Arinilda Campos MD 14,; Bruges, Ricardo MD 15,; Montesarchio, Vincenzo MD 16; Pazo-Cid, Roberto MD 17,; Hunter, Shannon MS 18,; Davenport, Eric MStat, MEcon 18,; Wang, Jinyi MS, MStat 18,; Kondo, Kaoru MSc 2,; Li, Mingshun MD 2,; Wyrwicz, Lucjan MD 19,
doi : 10.1200/JCO.23.00170
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.
Vergote, Ignace MD 1,,; Perez-Fidalgo, Jose Alejandro MD 2,; Hamilton, Erika Paige MD 3,; Valabrega, Giorgio MD 4,; Van Gorp, Toon MD 1,; Sehouli, Jalid MD 5,; Cibula, David MD 6,; Levy, Tally MD 7; Welch, Stephen MD 8,; Richardson, Debra L. MD 9,; Guerra, Eva M. MD 10,; Scambia, Giovanni MD 11,;
doi : 10.1200/JCO.22.02906
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair Analysis.
Knikman, Jonathan E. MSc 1,2; Wilting, Tycho A. MSc 1; Lopez-Yurda, Marta PhD 3; Henricks, Linda M. PhD 4; Lunenburg, Carin A.T.C. PhD 5,; de Man, Femke M. PhD 6; Meulendijks, Didier PhD 1,7,8,; Nieboer, Peter PhD 9; Droogendijk, Helga J. PhD 10; Creemers, Geert-Jan PhD 11; Mandigers, Caroline M.P.W. PhD 12; Imholz, Alexander L.T. PhD 13; Mathijssen, Ron H.J. PhD 6,; Portielje, Johanneke E.A. PhD 5,14; Valkenburg-van Iersel, Liselot PhD 15,; Vulink, Annelie PhD 16; van der Poel, Marlene H.W. PhD 17; Baars, Arnold PhD 18; Swen, Jesse J. PhD 19; Gelderblom, Hans PhD 5,; Schellens, Jan H.M. PhD 20,; Beijnen, Jos H. PhD 2,21,; Guchelaar, Henk-Jan PhD 19; Cats, Annemieke PhD 22,
doi : 10.1200/JCO.22.02780
Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL.
Lee, Shawn H.R. MD 1,2,3; Ashcraft, Emily MPH 4,; Yang, Wenjian PhD 1; Roberts, Kathryn G. PhD 5,; Gocho, Yoshihiro MD 1; Rowland, Lauren MS 1; Inaba, Hiroto MD, PhD 6,; Karol, Seth E. MD 6,; Jeha, Sima MD 6; Crews, Kristine R. PharmD 1; Mullighan, Charles G. MD 5,; Relling, Mary V. PharmD 1,; Evans, William E. PharmD 1,; Cheng, Cheng PhD 4,; Yang, Jun J. PhD 1,6,; Pui, Ching-Hon MD 5,6,7,,
doi : 10.1200/JCO.23.00880
Chromosomal Gains as a Favorable Prognostic Factor in Pediatric ALL.
Paulsson, Kajsa PhD 1,
doi : 10.1200/JCO.23.01760
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group.
Kamat, Ashish M. MD, MBBS 1,,; Apolo, Andrea B. MD 2; Babjuk, Marek MD, PhD 3,; Bivalacqua, Trinity J. MD, PhD 4,; Black, Peter C. MD, FACS, FRCSC 5,; Buckley, Roger MD, FRCSC 6,; Campbell, Matthew T. MD, MS 7,; Comperat, Eva MD, PhD 8,; Efstathiou, Jason A. MD, DPHIL 9,; Grivas, Petros MD, PhD 10,; Gupta, Shilpa MD 11,; Kurtz, Neil J. MD 12; Lamm, Donald MD, FACS 13,; Lerner, Seth P. MD, FACS 14,; Li, Roger MD 15,; McConkey, David J. PhD 16,; Palou Redorta, Joan MD, PhD 17,; Powles, Thomas MBBS, MD, MRCP 18,; Psutka, Sarah P. MD 19,; Shore, Neal MD, FACS 20,; Steinberg, Gary D. MD 21,; Sylvester, Richard ScD 22,; Witjes, J. Alfred MD, PhD 23,; Galsky, Matthew D. MD 24,
doi : 10.1200/JCO.23.00307
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.
Khurshid, Humera MD 1; Ismaila, Nofisat MD 2,; Bian, Jessica MD 3; Dabney, Raetasha MD 4,; Das, Millie MD 5,; Ellis, Peter MD 6,; Feldman, Jill BS, MA 7,; Hann, Christine MD, PhD 8,; Kulkarni, Swati MD 9,; Laskin, Janessa MD, PhD 10,; Manochakian, Rami MD 11,; Mishra, Deebya Raj MD 12; Preeshagul, Isabel DO 13,; Reddy, Pavan MD 14; Saxena, Ashish MD, PhD 15,; Weinberg, Frank MD, PhD 16,; Kalemkerian, Gregory P. MD 17
doi : 10.1200/JCO.23.01435
Erratum: nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors.
doi : 10.1200/JCO.23.02173
